These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31894732)

  • 1. Provisions for Health Sector Response to Substance Use Disorders in the Indian Policy: A Critique of the National Policy on Narcotic Drugs and Psychotropic Substances.
    Singh Balhara YP; Singh S
    J Psychoactive Drugs; 2020; 52(1):93-100. PubMed ID: 31894732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. India's National Narcotic Drugs and Psychotropic Substances policy, 2012: a 20th century document in the 21st century.
    Ambekar A; Rao R; Agrawal A
    Int J Drug Policy; 2013 Jul; 24(4):374-5. PubMed ID: 23380179
    [No Abstract]   [Full Text] [Related]  

  • 3. A review of the public sector substance use disorder treatment and prevention systems in Kenya.
    Jaguga F; Kwobah E
    Subst Abuse Treat Prev Policy; 2020 Jul; 15(1):47. PubMed ID: 32690036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WHO Expert Committee on Drug Dependence. Thirtieth report.
    World Health Organ Tech Rep Ser; 1998; 873():i-vi, 1-50. PubMed ID: 9615607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research progress on current situation and preventive measures for the narcotic and psychotropic drugs abuse in the elderly].
    Zhang B; Yan XY; Zhang XY; Jia ZW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Apr; 41(4):615-620. PubMed ID: 32344492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drugs: minors and harm reduction?].
    Armengaud JB; Baud CA; Broers B; Guillod L; Hasselgard-Rowe J; Junod V; Perrin D; Simon O
    Rev Med Suisse; 2023 Jun; 19(830):1127-1131. PubMed ID: 37283381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Abuse of prescribed sleeping, narcotic or psychotropic agents].
    Boxho P
    Rev Med Liege; 1999 Oct; 54(10):814-8. PubMed ID: 10605317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological Study of Mortality Rate from Alcohol and Illicit Drug Abuse in Iran.
    Ghoreishi SMS; Shahbazi F; Mirtorabi SD; Ghadirzadeh MR; Hashemi Nazari SS
    J Res Health Sci; 2017 Oct; 17(4):e00395. PubMed ID: 29233952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appraisal of the narcotic drugs and psychotropic substances (amendment) act, 2014.
    Mohapatra S; Rath N
    Asian J Psychiatr; 2015 Apr; 14():80-1. PubMed ID: 25838083
    [No Abstract]   [Full Text] [Related]  

  • 10. Shifting from an illegal-drug policy to a psychoactive substance policy.
    van der Linde F
    Soz Praventivmed; 2006; 51(3):128-9. PubMed ID: 17191533
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ratification of the Convention on Psychotropic Substances 1971 and its transposition into national legislation in the Federal Republic of Germany.
    Schröder O
    Bull Narc; 1982; 34(3-4):1-19. PubMed ID: 6926511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of drug policy liberalisation on willingness to seek help for problem drug use: A comparison of 20 countries.
    Benfer I; Zahnow R; Barratt MJ; Maier L; Winstock A; Ferris J
    Int J Drug Policy; 2018 Jun; 56():162-175. PubMed ID: 29731288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adoption and implementation of medications in addiction treatment programs.
    Knudsen HK; Abraham AJ; Roman PM
    J Addict Med; 2011 Mar; 5(1):21-7. PubMed ID: 21359109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statement on national drug policy. College on problems of drug dependence.
    Drug Alcohol Depend; 1997 Jul; 47(1):63-71. PubMed ID: 9279499
    [No Abstract]   [Full Text] [Related]  

  • 16. Evolution of Italian laws banning trafficking, use and abuse of psychotropic drugs.
    Di Luca NM; Busardò FP; Pirani F; Varì MR
    Ann Ist Super Sanita; 2020; 56(1):76-89. PubMed ID: 32242539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IMPLEMENTATION OF DRUG ADDICTS RIGHT TO HEALTH PROTECTION (SEPARATE ASPECTS).
    Shevchuk O; Rzhevska O; Korop O; Pyliuha L
    Georgian Med News; 2018 Mar; (276):166-172. PubMed ID: 29697401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating Addictions: Harm Reduction in Clinical Care and Prevention.
    Drucker E; Anderson K; Haemmig R; Heimer R; Small D; Walley A; Wood E; van Beek I
    J Bioeth Inq; 2016 Jun; 13(2):239-49. PubMed ID: 27112489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public policy statement on national drug policy. American Society of Addiction Medicine.
    J Addict Dis; 1994; 13(4):231-4. PubMed ID: 7734471
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessing the 'added value' of European policy on new psychoactive substances.
    Chatwin C
    Int J Drug Policy; 2017 Feb; 40():111-116. PubMed ID: 27956185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.